Imexpharm (STC:IMP) Treasury Stock: ₫-359 Mil (As of Mar. 2026)


STC:IMP Imexpharm Corp STC:IMP
97 GF Score
Price ₫42,900.00
GF Value ₫52,315.75
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Imexpharm Treasury Stock?

Imexpharm STC:IMP -0.12% 97 Treasury Stock is ₫-359 Mil as of Mar. 2026. GuruFocus rates STC:IMP with a GF Score™ of 97/100 and a GF Value™ of ₫52,315.75 (Modestly Undervalued). The stock has 2 warning signs investors should review.

Treasury stock is the portion of shares that a company keeps in their own treasury. Imexpharm's treasury stock for the quarter that ended in Mar. 2026 was ₫-359 Mil.

Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place.

Imexpharm Treasury Stock Historical Data

* Premium members only.

The historical data trend for Imexpharm's Treasury Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Imexpharm Treasury Stock Chart

Imexpharm Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Treasury Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only -358.60 -358.60 -358.60 -358.60 -358.60

Imexpharm Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Treasury Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -358.60 -358.60 -358.60 -358.60 -358.60
STC:IMP
97GF Score
Imexpharm Corp STC:IMP
Treasury Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Imexpharm Treasury Stock Calculation

The portion of shares that a company keeps in their own treasury. Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place. These shares don't pay dividends, have no voting rights, and should not be included in shares outstanding calculations.

Frequently Asked Questions Learn more about Treasury Stock →
What does a Treasury Stock of ₫-359 Mil mean?
Imexpharm (STC:IMP) has a Treasury Stock of ₫-359 Mil as of Mar. 2026. Treasury stock is a contra-equity item that records the amount of stock not issued to shareholders. View historical data for Imexpharm and its competitors.
Is Imexpharm's Treasury Stock too high?
Imexpharm's current Treasury Stock is ₫-359 Mil. Overall, Imexpharm has a GF Score™ of 97/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Imexpharm's Treasury Stock compare to ZTS and UTHR?
Imexpharm's Treasury Stock of ₫-359 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Treasury Stock for a Drug Manufacturers company?
A good Treasury Stock depends on the Drug Manufacturers industry context. However, Treasury Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Treasury Stock mean?
A high Treasury Stock can signal that a stock is expensive relative to its fundamentals. Treasury stock is a contra-equity item that records the amount of stock not issued to shareholders. View historical data for Imexpharm and its competitors. Imexpharm's current Treasury Stock is ₫-359 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Imexpharm stock overvalued right now?
Based on GuruFocus' analysis, Imexpharm (STC:IMP) is currently considered Modestly Undervalued. The stock's GF Value™ is ₫52,315.75, compared to a current price of ₫42,900.00 — trading 18% below its estimated fair value. The current Treasury Stock is ₫-359 Mil. Imexpharm's overall GF Score™ is 97/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Treasury Stock calculated?
Treasury Stock is calculated from a company's financial statements. For Imexpharm (STC:IMP), the current Treasury Stock is ₫-359 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Imexpharm (STC:IMP) Overvalued in 2026?

Based on GuruFocus' analysis, Imexpharm stock appears to be undervalued. The current stock price of ₫42,900.00 is trading 18% below its estimated GF Value™ of ₫52,315.75. GuruFocus considers Imexpharm to be Modestly Undervalued.

Key valuation signals for STC:IMP:

  • Treasury Stock: ₫-359 Mil
  • GF Value™: ₫52,315.75 vs. price of ₫42,900.00 (18% below fair value)
  • GF Score™: 97/100 with 2 warning signs

No single metric tells the full story. See the STC:IMP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Imexpharm Business Description

Address 4 Road 30/04 Street Ward 1, Cao Lanh City, Dongthap, VNM
Imexpharm Corp is engaged in the manufacture, import, export, and trade of pharmaceuticals and medicinal chemical products. The company's products include oral and injective antibiotic, digestion, central nervous system, cardiovascular, diabetes, musculoskeletal system, respiratory system, analgesic-anti-inflammatory, anti-allergy, ophthalmology, external drugs, and anti-parasitic, as well as vitamins and minerals.
97GF Score

Get the complete analysis for STC:IMP

Treasury Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₫42,900.00
Price
₫52,315.75
GF Value